Staphylococcus aureus meningitis: Experience with cefuroxime during a 16 year period in a Danish region

Scandinavian Journal of Infectious Diseases

Volumn 35, Issue 5, 2003, Pages 311-314

  Nørgaard, Mette ^a   Gudmundsdottir, Gudrun ^a   Larsen, Carsten Schade ^a   Schønheyder, Henrik Carl ^a  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFALOTIN; CEFUROXIME; MEROPENEM; METICILLIN; NAFCILLIN; PENICILLIN G; PENICILLINASE; VANCOMYCIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; ASPIRATION BIOPSY; BACTERIAL GROWTH; BACTERIAL MENINGITIS; BACTERIUM ISOLATE; BLOOD CULTURE; BRAIN ABSCESS; CEREBROSPINAL FLUID ANALYSIS; CHILD; COMMUNICABLE DISEASE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DENMARK; DRUG CHOICE; DRUG EFFICACY; FEMALE; HOSPITAL INFECTION; HUMAN; INFANT; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORTALITY; NONHUMAN; PENICILLIN RESISTANCE; REGISTER; RETROSPECTIVE STUDY; STAPHYLOCOCCUS AUREUS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CEFUROXIME; CHILD; CHILD, PRESCHOOL; CROSS INFECTION; DENMARK; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; MALE; MENINGITIS, BACTERIAL; MIDDLE AGED; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0038793429     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365540310004036     Document Type: Article

References (12)

1. Jensen AG, Espersen F, Skinhøj P, Rosdahl VT, Frimodt-Møller N. Staphylococcus aureus meningitis. A review of 104 nationwide, consecutive cases. Arch Intern Med 1993; 153: 1902-8.
2. Quintiliani R, Cooper BW. Current concepts in the treatment of staphylococcal meningitis. J Antimicrob Chemother 1988; 21(Suppl C): 107-14.
3. Lerche A, Rasmussen N, Wandall JH, Bohr VA. Staphylococcus aureus meningitis: a review of 28 consecutive community-acquired cases. Scand J Infect Dis 1995; 27: 569-73.
4. Everett ED, Strausbaugh LJ. Antimicrobial agents and the central nervous system. Neurosurgery 1980; 6: 691-714.
5. Forgacs P, Geyer CA, Freidberg SR. Characterization of chemical meningitis after neurosurgical surgery. Clin Infect Dis 2001; 32: 179-85.
6. Infection in Neurosurgery Working Party of the British Society for Antimicrobial Chemotherapy. The management of neurosurgical patients with postoperative bacterial or aseptic meningitis or external ventricular drain-associated ventriculitis. Br J Neurosurg 2000; 14: 7-12.
7. Federico G, Tumbarello M, Spanu T, Rosell R, Iacoangeli M, Scerrati M, Tacconelli E. Risk factors and prognostic indicators of bacterial meningitis in a cohort of 3580 postneurosurgical patients. Scand J Infect Dis 2001; 33: 533-7.
8. Cherubin CE, Eng RHK, Norrby R, Modai J, Humbert G, Overturf G. Penetration of newer cephalosporins into cerebrospinal fluid. Rev Infect Dis 1989; 11: 526-48.
9. Rogers DT, Russell AD. Comparative staphylolytic activity of cefoxitin, cephalothin and cefuroxime. J Antimicrob Chemother 1980; 6: 511-7.
10. Zygmunt DJ, Stratton CW, Kernodle DSL. Characterization of four β-lactamases produced by Staphylococcus aureus. Antimicrob Agents Chemother 1992; 36: 440-5.
11. Kossmann T, Hans V, Stocker R, Imhof HG, Joos B, Trentz O, Morganti-Kossmann MC. Penetration of cefuroxime into the cerebrospinal fluid of patients with traumatic brain injury. J Antimicrob Chemother 1996; 37: 161-7.
12. Muller C, Netland A, Dawson AF, Andrew E. The penetration of cefuroxime into the cerebrospinal fluid through inflamed and non-inflamed meninges. J Antimicrob Chemother 1980; 6: 279-83.